Genomics and Precision Health Database

---

Query Trace: Ovarian cancer[original query]>>Translation/Implementation Studies[Product Type]

Publication
Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2). Tokunaga Hideki et al. PloS one 2021 16(1) e0236907 Similar articles in PubMed
Pathogenicity Assessment of Variants for Breast Cancer Susceptibility Genes Based on BRCAness of Tumor Sample. Yoshida Reiko et al. Cancer science 2021 Jan Similar articles in PubMed
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian Cancers. Watson Catherine H et al. Targeted oncology 2021 Jan Similar articles in PubMed
MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer. Hutchcraft Megan L et al. Diagnostics (Basel, Switzerland) 2021 Jan 11(1) Similar articles in PubMed
Investigation of catechol-o-methyltransferase (COMT) Gene Val158Met polymorphism in ovarian cancer. Abaoglu Ipek Yagmur et al. Journal of the Turkish German Gynecological Association 2021 Jan Similar articles in PubMed
Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer. Hodan Rachel et al. Cancer medicine 2020 Dec Similar articles in PubMed
Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the RAD51C Gene. Sanoguera-Miralles Lara et al. Cancers 2020 Dec 12(12) Similar articles in PubMed
Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis. Yumiceba Verónica et al. Frontiers in endocrinology 2020 11585130 Similar articles in PubMed
Droplet Digital PCR for Large Genomic Rearrangements detection: a promising strategy in tissue BRCA1 testing. De Paolis Elisa et al. Clinica chimica acta; international journal of clinical chemistry 2020 Dec Similar articles in PubMed
Breast cancer associated pathogenic variants among women 61 years and older with triple negative breast cancer. Chávarri-Guerra Yanin et al. Journal of geriatric oncology 2020 Dec Similar articles in PubMed
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU. Sultova Elena et al. Archives of gynecology and obstetrics 2020 Dec Similar articles in PubMed
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge. Grill Sabine et al. Archives of gynecology and obstetrics 2020 Nov Similar articles in PubMed
Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer. Rana Huma Q et al. Gynecologic oncology 2020 Nov Similar articles in PubMed
Genotype-first approach to the detection of hereditary breast and ovarian cancer risk, and effects of risk disclosure to biobank participants. Leitsalu Liis et al. European journal of human genetics : EJHG 2020 Nov Similar articles in PubMed
Communication about positive BRCA1 and BRCA2 genetic test results and uptake of testing in relatives in a diverse Asian setting. Lee Daphne S-C et al. Journal of genetic counseling 2020 Nov Similar articles in PubMed
Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment. Yi Xiaoping et al. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2020 Nov 133111013 Similar articles in PubMed
Process evaluation of a culturally targeted video for Latinas at risk of hereditary breast and ovarian cancer. Hurtado-de-Mendoza Alejandra et al. Journal of genetic counseling 2020 Nov Similar articles in PubMed
Genomic Profiling Comparison of Germline BRCA and Non- BRCA Carriers Reveals CCNE1 Amplification as a Risk Factor for Non- BRCA Carriers in Patients With Triple-Negative Breast Cancer. Huang Xin et al. Frontiers in oncology 2020 10583314 Similar articles in PubMed
Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness. Lovejoy Leann A et al. Military medicine 2020 Nov Similar articles in PubMed
Prevalence of pathogenic variants in actionable genes in advanced ovarian cancer: a next-generation sequencing analysis of a nationwide registry study. Kang Sokbom et al. European journal of cancer (Oxford, England : 1990) 2020 Nov 141185-192 Similar articles in PubMed
Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic. Benusiglio Patrick R et al. European journal of medical genetics 2020 Nov 104098 Similar articles in PubMed
The impact of a cascade testing video on recipients' knowledge, cognitive message processing, and affective reactions: A formative evaluation. Aeilts Amber M et al. Journal of genetic counseling 2020 Nov Similar articles in PubMed
Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients. Grasel Rebeca Silveira et al. Frontiers in oncology 2020 10571330 Similar articles in PubMed
BRIP1, a gene potentially implicated in Familial Colorectal Cancer Type X. Martin-Morales Lorena et al. Cancer prevention research (Philadelphia, Pa.) 2020 Oct Similar articles in PubMed
ERCC3, a new ovarian cancer susceptibility gene? Stradella Agostina et al. European journal of cancer (Oxford, England : 1990) 2020 Oct 1411-8 Similar articles in PubMed
Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study. O'Shaughnessy Joyce et al. Breast cancer research : BCR 2020 Oct 22(1) 114 Similar articles in PubMed
Prevalence of germline variants in consensus moderate-to-high-risk predisposition genes to hereditary breast and ovarian cancer in BRCA1/2-negative Brazilian patients. Gomes Renan et al. Breast cancer research and treatment 2020 Oct Similar articles in PubMed
Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients. Lattimore Vanessa et al. Breast cancer research and treatment 2020 Oct Similar articles in PubMed
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. Fisher Julie G et al. Targeted oncology 2020 Oct Similar articles in PubMed
The Relationship between Risk Levels of Breast Cancer and Use of Early Diagnosis and Screening Services in Healthcare Workers in Turkey. Acikgoz Ayla et al. Iranian journal of public health 2020 Jul 49(7) 1289-1297 Similar articles in PubMed